Blood

Sickle cell mice showed early aging-like changes in blood

Mice followed up to one year of age showed abnormal blood formation, while repeated stem cell transplants increased mutations in blood-forming cells.

Paper by Mengna Chi, Ammar Husami, Fabienne Lucas, +7 more authorsPunam Malik · University of Cincinnati College of Medicine
Bone marrow crowded with abnormal cells contrasts with sparse healthy marrow, with crescent-shaped blood cells and laboratory mice nearby.

Our read

Mechanisms
Studied:
Experiments in humanized sickle cell disease mice, against age-, sex- and strain-matched normal mice
What changed:
Sickle cell mice developed early aging-like blood formation and mutation patterns, unlike normal mice
The catch:
The transplant experiment used repeated transplants, rather than a single transplant
In the record:
One of 50 papers on hematopoietic stem cell transplantation on record: 7 with results in people, 12 in animals.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Mice modeling human sickle cell disease were compared with normal mice matched for age, sex and strain in an animal experiment. Researchers tracked blood formation in blood and bone marrow up to one year of age. They sequenced 450 genes associated with blood cancers or related marrow disorders.

The sickle cell mice developed early aging-like changes. Blood production shifted toward myeloid cells, which include several kinds of immune cell. Mutations in blood-forming stem and precursor cells resembled those seen in aged mice and humans. A high proportion developed abnormal blood formation resembling myelodysplastic syndrome, a bone marrow disorder. They also had a greater burden of cell clones—groups descended from one cell. Repeated blood-forming stem cell transplants imposed regenerative stress and increased mutations, leading to the emergence or expansion of clones carrying cancer-driving mutations.

Why it matters

As more people with sickle cell disease survive into adulthood, understanding their increased blood-cancer risk matters. The authors suggest that early curative therapies may help avoid this risk.

Caveats

Repeated stem cell transplants tested regenerative stress in mice; they cannot determine the risk from a single transplant in a person with sickle cell disease.

Where the evidence stands

Hematopoietic stem cell transplantation

Mice: replicated by independent labs. Humans: a single group. Cells and worms or flies: nothing yet.
  • 16 independent labs in 10 countries
  • 71 trials, 9 with no results posted
  • Funders: National Institutes of Health and others
  • 4 of 26 findings with company ties

Stem cell differentiation

Cells and mice: replicated by independent labs. Worms or flies and humans: a single group.
  • 267 independent labs in 37 countries
  • 19 findings against
  • Funders: National Natural Science Foundation of China and others
  • 34 of 493 findings with company ties

Comments

Be the first to comment.